Monday, 18 Jan 2021 | Funding Deadline
The UK Musculoskeletal Translational Research Collaboration (MSK TRC) is a partnership between Versus Arthritis and the National Institute for Health Research. The partnership aims for the globally recognised centres of the UK to be at the forefront of musculoskeletal experimental medicine. The collaboration draws on the rich discovery, clinical and translational research landscape of the UK to accelerate new treatments and deliver cutting edge improvements for patients. The new collaboration operates an expansive, flexible, inclusive model. This builds on our previous investment in Experimental Arthritis and Osteoarthritis Treatment Centres and NIHR Biomedical Research Centres, welcoming and encompassing wider hubs and collaborators.
To bring momentum to the area, we will fund mechanistic experimental/translational medicine studies in humans across the areas of prevention, diagnosis or treatment that are aimed at priming the next transitional step.
Applications should be focused on an unmet arthritis need, within or across the collaboration’s themes. Studies that tackle related COVID-19 questions are also encouraged.
Deadline for proposals: 18th January 2021
Find out more here